Momelotinib package insert

heterogeneous MF data set evaluating a. JAK inhibitor, 12% of patients received momelotinib for ≥5 years. Momelotinib Package insert. Incyte

Momelotinib OL n=171 Momelotinib OL n=197 Momelotinib n=96 Momelotinib RT n=214 RUX RT n=216 Momelotinib OL n=64 Momelotinib OL n=40 Momelotinib n=22 Momelotinib RT n=104 BAT RTa n=46 Momelotinib OL n=92 Momelotinib OL n=40 Momelotinib n=33 Momelotinib RT n=130 DAN RT n=65 Momelotinib overall: N=725 ( ) aForty-six patients

by ST Oh 2024 Cited by 6Jakafi (ruxolitinib) [package insert]. Incyte Corp: Wilmington, DE Ojjaara (momelotinib) [package insert]. GSK: Durham, NC; 2024

Package insert. Hospira; 2024. 19. Cefazolin. Package insert. GSK; 2024. 20. Ceftriaxone. Package insert. Sandoz; 2024. 21. Daptomycin. Package insert

Momelotinib was associated with a significant improvement in total symptom score, splenic response, and transfusion independence. Package insert. GlaxoSmithKline plc; 2024. Accessed September

Ojjaara (momelotinib) 150 mg tablets days Ojjaara (momelotinib) 200 mg tablets days PROCEDURES AND BILLING CODES To report provider services, use appropriate CPT codes, Alpha Numeric (HCPCS level 2) codes, Revenue codes, and/or ICD diagnostic codes. N/A REFERENCES Ojjaara [package insert]. Durham, NC: GlaxoSmithKline.;

Ojjaara (momelotinib) 150 mg tablets days Ojjaara (momelotinib) 200 mg tablets days PROCEDURES AND BILLING CODES To report provider services, use appropriate CPT codes, Alpha Numeric (HCPCS level 2) codes, Revenue codes, and/or ICD diagnostic codes. N/A REFERENCES Ojjaara [package insert]. Durham, NC: GlaxoSmithKline.;

The Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) Package insert. GlaxoSmithKline plc; 2024. Accessed September 18

From the manufacturer's website: Momelotinib approved in the US for treatment of myelofibrosis patients with anaemia. package insert. Clinical